Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS) (original) (raw)

Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant

BMC medicine, 2017

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

Davide Luciani

Blood, 2002

View PDFchevron_right

Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant

Gentian Denas, Vittorio Pengo, Serena Passamonti

Thrombosis Research, 2015

View PDFchevron_right

Antiprothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study

sandra zampieri

Journal of Thrombosis and Haemostasis, 2007

View PDFchevron_right

Hypercoagulability resulting from opposite effects of lupus anticoagulants is associated strongly with thrombotic risk

Véronique Regnault

Haematologica, 2007

View PDFchevron_right

Distribution and Clinical Significance of Lupus Anticoagulant and Anticardiolipin Antibody in 349 Patients with Systemic Lupus Erythematosus

Dr. Sujat Paul

Internal Medicine, 1992

View PDFchevron_right

Haemostatic factors associated with vascular thrombosis in patients with systemic lupus erythematosus and the lupus anticoagulant

Toyoshi Inoguchi

Annals of the Rheumatic Diseases, 1991

View PDFchevron_right

Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome

Patrizia Della Valle

Haematologica, 1999

View PDFchevron_right

Thrombophilia in Systemic Lupus Erythematosus: A Review of Multiple Mechanisms and Resultant Clinical Outcomes

Robert Sokol

Pregnancy Thrombophilia - The Unsuspected Risk, 2013

View PDFchevron_right

The laboratory diagnosis of lupus anticoagulant in patients on oral anticoagulation

Luke Coyle

Clinical and Laboratory Haematology, 2006

View PDFchevron_right

Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus

Domenico Ferro

Journal of Clinical Pathology, 1992

View PDFchevron_right

2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome

Mark Roest

Blood, 2004

View PDFchevron_right

Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times

Barbara Alving

The American Journal of Medicine, 1990

View PDFchevron_right

Different clinical presentations of a lupus anticoagulant in the same family

H. Knecht

Klinische Wochenschrift, 1991

View PDFchevron_right

Cerebral Vein Thrombosis and Lupus Anticoagulant Antibodies

Marco Marietta

Clinical and Applied Thrombosis/Hemostasis, 2001

View PDFchevron_right

Clinical Importance of Positive Test Results for Lupus Anticoagulant and Anticardiolipin Antibodies

Henry Homburger

Mayo Clinic Proceedings, 2004

View PDFchevron_right

Indication and outcome of lupus anticoagulant and antiphospholipid antibodies testing in routine clinical practice

Sylvana Sackey-Sam

Rheumatology Advances in Practice, 2021

View PDFchevron_right

A Comparison of Lupus Anticoagulant Positive Patients With Clinical Picture of Antiphospholipid Syndrome and Those Without

Vittorio Pengo, P. Gresele

Arteriosclerosis Thrombosis and Vascular Biology, 2007

View PDFchevron_right

Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants

Marc Hoylaerts

Blood, 2010

View PDFchevron_right

Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events

Rico Bastian

Rheumatology, 2005

View PDFchevron_right

Lupus Anticoagulant Syndrome: A Case Report

Tara Khan

Journal of Emergency Medicine, 2010

View PDFchevron_right

Single Center Review of Clinicopathological Characterization in 77 Patients with Positive Lupus Anticoagulant Antibodies

George Tregson Roberts

Hematology, 2003

View PDFchevron_right

Lupus anticoagulant in patients with peripheral vascular disease: A prospective study

Ian Lane

European Journal of Vascular and Endovascular Surgery, 1995

View PDFchevron_right

Protein S and Anticardiolipin Antibodies in Patients with Lupus Anticoagulant with or Without Thrombosis

Robert Dudczak

Thrombosis and Haemostasis, 1987

View PDFchevron_right

Evaluation Of Laboratory Tests For Lupus Anticoagulant In A Group Of Chinese Lupus Patients

Edmund Li

Pathology, 1994

View PDFchevron_right

Under crossfire: thromboembolic risk in systemic lupus erythematosus

Maria Efthymiou

Rheumatology

View PDFchevron_right

The Effects of Indirect- and Direct-Acting Anticoagulants on Lupus Anticoagulant Assays

Franklin Bontempo

American Journal of Clinical Pathology, 2017

View PDFchevron_right

Detection of low levels of lupus anticoagulant antibodies

Fernando Ferrando

Thrombosis Research, 2005

View PDFchevron_right

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists

Sylvain Audia

Rheumatology (Oxford, England), 2018

View PDFchevron_right

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

M. Marietta, P. Gresele, Vittorio Pengo

Thrombosis Research, 2010

View PDFchevron_right

Lupus nephritis and Raynaud’s phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies

Kitti Totemchokchyakarn

Clinical Rheumatology, 2008

View PDFchevron_right

Significance of the lupus anticoagulant

Luis Ramiro Peñafiel Espinoza

American Journal of Hematology, 1986

View PDFchevron_right

Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS) (original) (raw)

Related papers